Healthcare provider profile · identity verified

Sumathi Devarajan, MD

Family Practice · PORTLAND, OR · NPI 1992874267

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	439	78
Gabapentin	Gabapentin	372	54
Oxycodone Hcl	Oxycodone Hcl	289	36
Eliquis	Apixaban	275	30
Lisinopril	Lisinopril	231	43
Duloxetine Hcl	Duloxetine Hcl	226	24
Potassium Chloride	Potassium Chloride	224	29
Levothyroxine Sodium	Levothyroxine Sodium	221	41
Amlodipine Besylate	Amlodipine Besylate	212	50
Furosemide	Furosemide	163	30
Tamsulosin Hcl	Tamsulosin Hcl	145	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	138	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	135	42
Omeprazole	Omeprazole	133	31
Metoprolol Succinate	Metoprolol Succinate	122	20
Trazodone Hcl	Trazodone Hcl	122	21
Diclofenac Sodium	Diclofenac Sodium	120	31
Citalopram Hbr	Citalopram Hydrobromide	113	18
Xarelto	Rivaroxaban	112	suppressed
Losartan Potassium	Losartan Potassium	108	22
Pantoprazole Sodium	Pantoprazole Sodium	100	16
Sertraline Hcl	Sertraline Hcl	97	19
Baclofen	Baclofen	96	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	95	23
Hydrochlorothiazide	Hydrochlorothiazide	90	17
Metoprolol Tartrate	Metoprolol Tartrate	90	14
Methadone Hcl	Methadone Hcl	89	suppressed
Torsemide	Torsemide	85	15
Mirtazapine	Mirtazapine	80	13
Metformin Hcl	Metformin Hcl	76	20
Atenolol	Atenolol	71	11
Bupropion Xl	Bupropion Hcl	70	11
Fluticasone Propionate	Fluticasone Propionate	69	21
Pregabalin	Pregabalin	68	14
Alendronate Sodium	Alendronate Sodium	67	suppressed
Carvedilol	Carvedilol	66	13
Hydromorphone Hcl	Hydromorphone Hcl	63	suppressed
Clonazepam	Clonazepam	60	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	60	11
Buspirone Hcl	Buspirone Hcl	58	suppressed
Allopurinol	Allopurinol	55	suppressed
Tramadol Hcl	Tramadol Hcl	53	11
Spironolactone	Spironolactone	51	suppressed
Simvastatin	Simvastatin	50	suppressed
Clopidogrel	Clopidogrel Bisulfate	49	suppressed
Ondansetron Odt	Ondansetron	49	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	48	suppressed
Humalog Kwikpen U-100	Insulin Lispro	47	11
Pravastatin Sodium	Pravastatin Sodium	47	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	44	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	44	suppressed
Famotidine	Famotidine	43	suppressed
Farxiga	Dapagliflozin Propanediol	43	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Lactulose	Lactulose	40	suppressed
Olanzapine	Olanzapine	40	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	40	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	39	11
Glipizide	Glipizide	38	suppressed
Levetiracetam	Levetiracetam	38	suppressed
Mupirocin	Mupirocin	38	11
Jardiance	Empagliflozin	37	13
Montelukast Sodium	Montelukast Sodium	37	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	36	suppressed
Donepezil Hcl	Donepezil Hcl	36	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Lidocaine	Lidocaine	35	suppressed
Nyamyc	Nystatin	35	15
Risperidone	Risperidone	35	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	34	suppressed
Finasteride	Finasteride	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	29	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	29	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	28	suppressed
Terazosin Hcl	Terazosin Hcl	27	suppressed
Trulicity	Dulaglutide	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Cephalexin	Cephalexin	25	11
Ezetimibe	Ezetimibe	25	suppressed
Latanoprost	Latanoprost	25	suppressed
Spiriva Respimat	Tiotropium Bromide	25	suppressed
Creon	Lipase/Protease/Amylase	24	suppressed
Divalproex Sodium	Divalproex Sodium	24	suppressed
Insulin Aspart Flexpen	Insulin Aspart	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	24	suppressed
Prednisone	Prednisone	24	suppressed
Vraylar	Cariprazine Hcl	23	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	22	22
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Naproxen	Naproxen	22	suppressed
Zonisamide	Zonisamide	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Glipizide Er	Glipizide	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Liothyronine Sodium	Liothyronine Sodium	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Rytary	Carbidopa/Levodopa	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Nystatin	Nystatin	15	11
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Nystop	Nystatin	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Acetazolamide	Acetazolamide	12	suppressed
Azithromycin	Azithromycin	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Dexamethasone	Dexamethasone	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error